Meeker David P

President and CEO at RYTM; Director at TRVI; ExecVP,Chief Operating Officer at GENZYME CORP

Sold, on record
$13.2M
Dollars the filings state
Form 4 sales
10
Latest Sep 14, 2026
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

  • RYTMRHYTHM PHARMACEUTICALS, INC.President and CEO
  • TRVITrevi Therapeutics, Inc.Director
  • GENZYME CORPExecVP,Chief Operating Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale GENZYME CORPPlan not stated
    May 25 2010

    Sold 2,732 shares at $45.60 ($125k)

    Meeker David P, ExecVP,Chief Operating Officer

    Sold 21.4% of holdings ($583k position)10,045 shares leftFiling

  2. 2 Form 4 sale RYTMNo plan
    Feb 1 +5000 days

    Sold 4,361 shares at $45.06 ($197k)

    Meeker David P, President and CEO

    No 10b5-1 planSold 3.5% of holdings ($5.7M position)121,099 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale RYTMNo plan
    Mar 19 +47 days

    Sold 45,494 shares at $39.22 ($1.8M)

    Meeker David P, President and CEO

    No 10b5-1 planSold 20.7% of holdings ($8.6M position)174,605 shares leftFiling

  4. 4 Form 4 sale TRVINo plan
    Aug 27 +161 days

    Sold 4,555 shares at $2.93 ($13k)

    Meeker David P, Director

    No 10b5-1 planSold 1.3% of holdings ($1M position)352,489 shares leftFirst sale on recordFiling

  5. 5 Form 4 sale RYTMNo plan
    Feb 4 +161 days

    Sold 4,278 shares at $59.43 ($254k)

    Meeker David P, President and CEO

    No 10b5-1 planSold 2.2% of holdings ($11.5M position)189,927 shares leftFiling

  6. 6 Form 4 sale RYTMRoutine
    Feb 19 +15 days

    Sold 9,896 shares at $57.22 ($566k)

    Meeker David P, President and CEO

    10b5-1 planSold 4.7% of holdings ($12.1M position)201,281 shares left2.3x usual sizeFiling

  7. 7 Form 4 sale RYTMUnusual
    Jun 3 +104 days

    Sold 43,620 shares at $65.04 ($2.8M)

    Meeker David P, President and CEO

    10b5-1 planSold 17.8% of holdings ($16M position)201,825 shares left6.1x usual sizeFiling

  8. 8 Form 4 sale RYTMUnusual
    Sep 14 +468 days

    Sold 50,000 shares at $102.67 ($5.1M)

    Meeker David P, President and CEO

    10b5-1 planSold 17.3% of holdings ($29.7M position)239,258 shares left5.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (10)

Form 144 notices and Form 4 sales by Meeker David P
Source
Sep 14, 2026RYTMPresident and CEOForm 4 sale50,000$5.1M17.3%UnusualSEC
Jun 3, 2025RYTMPresident and CEOForm 4 sale43,620$2.8M17.8%UnusualSEC
Feb 19, 2025RYTMPresident and CEOForm 4 sale9,896$566k4.7%RoutineSEC
Feb 4, 2025RYTMPresident and CEOForm 4 sale4,278$254k2.2%No planSEC
Aug 27, 2024TRVIDirectorForm 4 sale4,555$13k1.3%No planSEC
Mar 19, 2024RYTMPresident and CEOForm 4 sale45,494$1.8M20.7%No planSEC
Feb 1, 2024RYTMPresident and CEOForm 4 sale4,361$197k3.5%No planSEC
May 25, 2010GENZYME CORPExecVP,Chief Operating OfficerForm 4 sale2,732$125k21.4%Plan not statedSEC
May 21, 2010GENZYME CORPExecVP,Chief Operating OfficerForm 4 sale16,488$809k77.8%UnusualSEC
Aug 15, 2008GENZYME CORPPresident LSD TherapeuticsForm 4 sale17,790$1.5M90.4%UnusualSEC